ArticleCancer biology & therapy2026

Real-world efficacy of Bruton tyrosine kinase inhibitor based maintenance therapy in diffuse large B-cell lymphoma: a multicenter retrospective cohort study with external historical control.

Li-Wei Lyu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.